Acetazolamide (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the Acetazolamide drug offered from Sagent Pharmaceuticals. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | acetazolamide sodium |
| SUBSTANCE NAME: | ACETAZOLAMIDE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-06-15 |
| END MARKETING DATE: | 0000-00-00 |
Acetazolamide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Acetazolamide from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/5mL) |
| START MARKETING DATE: | 2012-06-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-817_c4d1a6b3-d119-41ee-8c5f-a4db81ccd269 |
| PRODUCT NDC: | 25021-817 |
| APPLICATION NUMBER: | ANDA200880 |
Other ACETAZOLAMIDE SODIUM Pharmaceutical Manufacturers / Labelers:
